Antibody-mediated Rejection Market Size
Market Size in USD Mn
CAGR12.8%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 12.8% |
| Market Concentration | High |
| Major Players | CSL Behring, Hansa Biopharma AB, Viela Bio, Janssen Biotech, Pfizer and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Antibody-mediated Rejection Market Analysis
The antibody-mediated rejection market is estimated to be valued at USD 142.7 Mn in 2025 and is expected to reach USD 331.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 12.8% from 2025 to 2032. The market is mainly driven by increasing solid organ transplant procedures globally along with rising investments in development of novel therapeutics for treatment of antibody-mediated rejection post-transplant.